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CHAPTER FOUR 
SOCIAL MARKETING:  
IMMUNIZING AGAINST UNETHICAL PRACTICE 





Do you think that social marketing is more ethical than commercial 
marketing? If you do, you are in good company, as straw polls we have 
taken at conferences show that virtually everyone (95% or more) thinks 
so. But what justifies this belief? Social marketers may be well meaning, 
and perhaps more so than commercial marketers, but is there anything 
about social marketing that makes it inherently ethical?  
 
We argue that social marketing is not inherently ethical and that there 
are unique ethical concerns that confront, or perhaps ought to confront, 
social marketers. As commercial and social marketers use the same 
marketing tools, social marketers cannot claim to be inherently more 
ethical than commercial marketers in terms of the ‘means’. We may well 
hope that social marketers subscribe to a high standard of ethics in their 
use of marketing tools, as has been urged by some (Kirby & Andreasen, 
2001; Kotler & Andreasen, 2007; Murphy & Bloom, 1992), but there is 
certainly no assurance that they do so simply because they are social 
marketers. 
 
Where social and commercial marketers are held to differ is in terms of 
the ‘ends’ of the marketing effort, in the goals or objectives of each: social 
marketers aim at a social or common good. However, does this ensure that 
social marketers are ethical? We suggest not as what constitutes the social 




example of immunization and vaccinations 1 that we develop here. We 
chose this particular example because it has a long history as a social 
marketing target and has evoked much public debate highlighting the 
issues we wish to discuss. However, as we argue elsewhere (Holden & 
Cox, 2013), the issues raised are relevant to many domains of social 
marketing.  
 
The ultimate objective of this chapter is to reflect on what constitutes 
ethical behaviour in our field. We are not questioning the ethicality of 
social marketers but rather questioning the presumption of ethicality. 
Marketing for the social good may be praiseworthy in many instances, but 
this does not yet establish the ethical legitimacy of the relevant marketing 
practice.  
 
Our approach here, like that of Brenkert (2001, 2002), is philosophical 
rather than empirical. To some extent, this means we raise tough 
questions, and we do not provide answers! Nonetheless, we believe social 
marketing can benefit if there is a willingness to understand the unique 
ethical challenges faced and to address the questions raised. 
Commercial vs. social marketing of vaccinations 
Typically, social marketers are distinguished from commercial 
marketers primarily by their motives (Andreasen, 1995; Andreasen, 2006; 
Dann, 2010; Donovan & Henley, 2010; Grier & Bryant, 2005; Kotler & 
Zaltman, 1971; Smith, 2000). Donovan and Henley (2010: 1) assert that 
the matter is straightforward: ‘If the well-being of the community is not 
the goal, then it isn’t social marketing’. We believe the situation is not 
quite that simple. Consider the following two scenarios as we explore 
what is excluded from social marketing: 
 
Scenario A: CSL is an Australian-based global marketer of vaccines 
(http://www.flu.com.au/) and Sanofi is a French-based global competitor 
(http://www.sanofipasteur.com/EN/value-of-vaccines.html). Each markets 
and promotes vaccines to consumers through websites (see examples 
given) and other media. 
 
                                                          
1 In line with common usage, we use the word vaccination to refer to a wide 
variety of pharmaceutical products that offer immunity to a wide variety of 
diseases. Immunisation is the outcome of applying a vaccination. 
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Scenario B: Immunise Australia (http://immunise.health.gov.au), the 
Public Health Agency of Canada (http://www.phac-aspc.gc.ca/im/index-
eng.php) and the Center for Disease Control in the US 
(http://www.cdc.gov/vaccines/) all market and promote vaccines to 
consumers through websites and other media. 
 
Both the commercial marketers and the government health agencies 
are promoting vaccinations, so both are marketing a social good. The 
standard explanation given for why B is an example of social marketing 
and A is not is that the commercial marketer generates profits if their 
marketing effort is successful. The commercial marketers are promoting a 
social or public good, but there is also a self-serving motivation to 
generate a profit (Donovan & Henley, 2010; Gordon et al., 2006; Smith, 
2000). 
 
Donovan (2011: 9) states:  
 
Where the primary, if not only motivation, is to enhance the public good, 
then it is social marketing. Where the primary motivation is to turn a 
profit, even where this contributes to the public good, it is not social 
marketing–simple.  
 
We believe that this suffices for most practical purposes, but it may 
inadvertently suggest that the social marketer is motivated only by the 
social good. Just as we might question whether a commercial marketer 
who claims to serve customer needs above all else is being honest, so 
might we question a social marketer who claims to prioritize social good 
above all else. 
 
Social marketers may have ulterior and potentially self-serving 
motivations beyond advancing the social good. Social marketers operate 
with financial imperatives: they are obliged to set and meet budgets, to 
maximize the impact for the expenditure available and, ultimately, to show 
a positive return on investment (Lingane & Olsen, 2004). Obtaining 
funding within the competitive environment where they seek support 
requires evidence of results and good management skills (Andreasen, 
2002). The individuals that make up social marketing organizations also 
have personal motivations, such as the satisfaction of doing a job well, 






The public health agencies that are marketing vaccinations (Scenario 
B) may not have direct financial interests in the uptake of vaccination, but 
there are financial consequences that are likely to arise from the success or 
otherwise of their efforts. The marketer as an organization and the 
employees making up the organization have indirect financial (and, 
indeed, existential) interests in the success of their marketing efforts. 
 
Both social and commercial marketers, therefore, are guided by 
multiple goals. A commercial marketer can be readily distinguished from 
the social marketer by whether or not there is a reportable profit, but this 
does not prove that advancing the social good is their sole or even primary 
objective. A case in point is the ISIS Group (http://www.isisgroup.org/): a 
corporate advisory business (ISIS Asia-Pacific) operates primarily to fund 
international development (ISIS Foundation). Similarly, a social marketer 
may have objectives and priorities aside from the social good. 
 
Knowledge of intentions and motivations relies in a large part upon 
self-reporting, but this in turn relies on self-knowledge and honesty. Can 
we trust what people say? This problem confronts those who would 
endeavour to treat non-vaccinators differently depending on their stated 
reason for non-vaccination (Asveld, 2008). The law similarly acknowledges 
the difficulties of intentions such that they are rarely admitted in courts of 
law as a basis for conviction – cases of pre-meditated murder / murderous 
intent being one of the few exceptions. The motivations and intentions 
underlying the actions of an organization can be varied – financial, 
political and personal – and may or may not be clearly stated. 
Social marketing for and against vaccination 
Even if motivation for the social good is the primary motivation of a 
social marketer, how clear is this goal? To explore this problem, let us add 
a third scenario: 
 
Scenario C: Many public interest groups encourage people to ‘be 
informed’ about vaccination, to ask how necessary it is and to understand 
its limitations and possible side effects. These groups market and promote 
non-vaccination through websites and other media (e.g. avn.org.au, 
vaccines.procon.org and www.vaccines.me/). 
 
Scenarios B and C include two types of not-for-profit agency: one 
promoting vaccination (B) and the other promoting non-vaccination (C). 
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Some might be inclined to dismiss the idea that so-called anti-vaccinators 
are social marketers, but this presupposes that vaccination is 
unequivocally in the social good. Who defines what is in the best interests 
of society? Do the anti-vaccinators have a good and legitimate role to play 
in answering this question? We argue that they do. 
 
As knowledge is never certain, and as marketers of vaccinations – 
commercial or social – may have other objectives aside from the social 
good, there appears to be value in anti-vaccination marketing. This is not 
to say that it is legitimate for anti-vaccinators to disseminate falsehoods 
knowingly: this ethical provision applies equally to all marketers, 
commercial and social. Social marketers are challenged, however, as 
‘social good’ is vague, contested and difficult to define (Bayer et al., 2007; 
Polonsky & Grau, 2008). It is unclear, then, whether pro-vaccinators or 
anti-vaccinators can make an unequivocal case that they, and they alone, 
are furthering the social good. 
 
It therefore appears that the goals of social marketers, like the goals of 
public health, ‘are too often assumed or simply asserted, rather than 
cogently explained or justified’ (Gostin et al., 2007: 57). While most 
social marketers hold that social marketing should consider the ethics of 
their methods (means), there are a number that take the view that 
examining the ethicality of the social good is not the responsibility of 
social marketing (Donovan & Henley, 2010; Kirby & Andreasen, 2001; 
Lee & Kotler, 2011). However, if this is the case, then this makes social 
marketers little more than ‘hired guns’, as described by Andreasen on a 
social marketing list-server (Lee & Kotler, 2011). This fails to set a social 
marketer apart ethically from any other marketer. Indeed, the social 
marketer holding this view sounds little different from the tobacco 
industry lobbyist Nick Naylor in the film Thank You for Smoking, who 
justifies his professional practice with the statement: ‘I need to pay the 
mortgage.’ In an internal monologue, Naylor describes this as ‘The yuppie 
Nuremberg defence.’  
 
We believe that social marketers are obliged to examine the bona fides 
of their claims to advance the social good, despite the difficulties of doing 
so; to not do so is to engage in ‘ethics avoidance’ (Cribb, 2010). To 
examine the social good is of critical importance as it results in the 
determination of objectives of social marketing programs affecting 





The ethicality of all social marketing should be subject, therefore, to 
critical scrutiny. Examining the ethicality of methods is important to both 
social and commercial marketing. Examining the ethicality of goals is 
especially important in the case of social marketing, where the social good 
is defined and marketed independently of, and possibly in violation of, 
individual wishes. In this vein, we trace the emergence and contribution of 
‘for’ and ‘against’ positions in vaccination marketing.  
The social good of immunization – for and against 
The notion that ‘prevention is better than the cure’, stated by Erasmus 
long before vaccination and social marketing were even conceived, 
underlies many forms of social marketing, such as primary prevention in 
public health (Carter et al., 2012). The principle motivates efforts to 
encourage people to vaccinate but also to wear seatbelts/helmets, engage 
in activity/exercise, breastfeed, eat healthily, get appropriate health checks, 
etc. Some social marketing is aimed at discouraging behaviours (e.g. 
consumption of alcohol, fast-food, cigarettes, drugs, etc.), but the general 
principle is the same: in these contexts, the promotional effort encourages 
foregoing immediate or short-term gains in place of some greater benefit 
in the longer run. 
 
The first great drive for immunization was against smallpox. This 
virulent disease could kill up to 20% of those infected and would leave 
many of the survivors permanently scarred, blind or both. However, some 
cultures, notably China, India and Africa, had found that immunity could 
be induced by inoculating uninfected persons with the crusts of smallpox 
sores. This practice was introduced to France by Boyer, to the UK by Lady 
Montagu (wife of the ambassador to Turkey) and to the US by Dr Zabdial 
Boylston in Boston in the early 18th century (White, 1993 / 1896). 
Inoculation with smallpox, also called variolation, led to the development 
of immunity – but there was a drawback. Up to 2% of those variolated 
might be expected to die. 
 
Medical and theological authorities in the UK, Europe and the US 
vigorously denounced variolation as poisoning, murder, blasphemy and 
more generally as being against the will of God (White, 1993 / 1896). 
Voltaire (2001 / 1909-14) famously ventured his own views, which neatly 
capture the conflict of those for and against:  
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[Europeans consider] the English are fools and madmen. Fools, because 
they give their children the small-pox to prevent their catching it; and 
madmen, because they wantonly communicate a certain and dreadful 
distemper to their children, merely to prevent an uncertain evil. The 
English, on the other side, call the rest of the Europeans cowardly and 
unnatural. Cowardly, because they are afraid of putting their children to a 
little pain; unnatural, because they expose them to die one time or other of 
the small-pox. 
 
The development of vaccination, where patients were inoculated with 
cowpox, offered immunity against smallpox at a much-reduced risk 
(Jenner, 1909–1914 / 1798). Nonetheless, strong opposition emerged again 
from both the medical profession and from the church. No sooner had 
Jenner published his ideas about vaccination than an Anti-Vaccination 
Society was established in Boston in 1798 (White, 1993 / 1896). Jenner’s 
idea was lambasted publically, which gave rise to the famous political 
cartoon featuring vaccinated patients having cows erupt from their bodies: 
 





Despite the negative responses, the evidence that vaccination could 
prevent infection by smallpox with very small risk was overwhelming and 




promoting vaccination. The Vaccination Act of 1840 banned the practice 
of variolation and promoted vaccination by offering it for free. The 
Compulsory Vaccination Act was introduced in 1853. 
 
The anti-vaccination movement continued. Offit, a paediatrician and 
pro-immunization advocate, stated in an interview that the anti-vaccinators 
‘were great at mass marketing. It was a print-oriented society. They were 
great pamphleteers’ (Wallace, 2009). Today’s anti-vaccinators are equally 
marketing savvy and the opposition remains both medical and theological.  
 
While not necessarily well articulated, the anti-vaccinators offer an 
important contribution. They highlight the fact that whether vaccination is 
good for the community is disputed. For instance, the fact that different 
vaccinations are required in different jurisdictions indicates that not all 
agree on what is in the best interests of the community. The MMR 
(measles, mumps and rubella) vaccine has been banned in Japan since 
1993 due to the side effects associated with the mumps component of the 
vaccine (Hope, 2001). While the most recent meta-analysis confirms these 
negative events (Demicheli et al., 2012), it would appear that most public 
health agencies consider these acceptable risks while the Japanese do not. 
 
Another important contribution of anti-vaccinators, which again is not 
always necessarily clearly articulated, is that universal social marketing 
efforts such as the promotion of mass vaccination can impinge on 
individual liberties, autonomy and self-determination.  
Social good vs. individual rights 
Many social marketing ventures face the same challenge confronted in 
immunization: what is good for the community is not necessarily good for 
the individual, even though the individual is necessarily embedded within 
the community. The basic conflict is one of social good versus individual 
rights or, more simply, social marketing’s ‘interference in personal 
choices’ (Dawson & Verweij, 2010: 89). 
 
Social marketers are mostly interested in advancing what they 
understand to be the social good, and they are less inclined to 
accommodate individual choice or fully acknowledge the roles that liberty 
and autonomy play in many conceptions of the social good. This puts 
social marketers in a precarious position ethically. In effect, by their 
efforts, they are saying to their markets: ‘we have decided what is best for 
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you – whether you like it or not.’ Of course, social marketing is a process 
that incorporates extensive public consultation (e.g. Andreasen, 2002), but 
even if that process is unbiased and fair – and that is difficult to establish, 
even if the process is transparent – the outcome will effectively operate 
against those with a contrary view. This requires unflagging scrutiny of 
the justice of marketing programs. 
 
Social good based on ‘a rough-and-ready utilitarian calculation is 
probably what the authorities have in mind when they decide to use 
preventive measures [such as vaccination] regardless of the risk they are 
imposing on a certain number of people’ (Häyry & Häyry, 1989, cited by 
Holland, 2007: 153). Pro-vaccinators (and social marketers in general) are 
therefore adopting a utilitarian argument that the social good is represented 
by the greatest good for the greatest number (Bentham, 1961 / 1789). 
 
The anti-vaccinators invoke a different ethical principle that is a 
relevant challenge to most social marketing: that the rights of choice of 
individuals ought not to be breached, even if for their own good. John 
Stuart Mill, in his essay On Liberty (Mill, 1991 / 1859: 30), states that 
‘…the only purpose for which power can be rightfully exercised over any 
member of a civilized community, against his will, is to prevent harm to 
others. His own good, either physical or moral, is not a sufficient warrant.’ 
  
The problem is that what is good for the individual does not 
necessarily align with what is good for the community. Individual 
preferences may be subjective but are nonetheless deemed important from 
an ethical point of view. It is noteworthy and ironic perhaps that 
commercial marketers are probably more sensitive to individual 
preferences than social marketers. 
 
Even if subjective issues are removed, the calculation of risk at a 
community level does not necessarily correspond to the risk experienced 
at the individual level. As more and more people are vaccinated, an 
unvaccinated individual’s risk of infection declines. Ultimately, when herd 
immunity is attained, the calculation for the individual can shift 
significantly to a point where the risks associated with vaccination, even if 
small, may come to outweigh the risk of contracting the disease. This then 
raises the free-rider problem. Specifically, herd immunity describes a 
positive externality whereby the benefits accrue to others beyond those 
who have ‘paid’ (i.e. been vaccinated). Interestingly, even social marketers 




may nonetheless agree that the free-rider problem represents an unjust 
distribution of the good. The ethical question now becomes a 
determinately non-utilitarian one: to what extent, and in what ways, can 
free-rider considerations trump claims to choose a course of action for 
oneself? 
 
Mill’s (1991 / 1859) harm principle can be invoked so that individual 
rights might be curtailed if non-vaccinators are judged to bring harm to 
others. Offit’s (2011) book entitled Deadly Choices: How the anti-vaccine 
movement threatens us all is one such statement of this notion. However, 
Offit’s hyperbole, combined with the related issue of the ethical obligation 
on an individual to vaccinate in order to protect others (Bayer et al., 2007; 
Diekema & Marcuse, 2007), leads us to the final issue: consideration of 
the appropriate level of influence that might be adopted by social 
marketers. 
Means: influence and coercion 
At this final point, we give some brief consideration to the important 
issue of the means of social marketing. As noted earlier, the means of 
marketing are common to both commercial and social marketing and so 
form no basis for defending social marketing as being more ethical than 
commercial marketing. However, the lack of clarity around what 
constitutes the social good and how it might be legitimately advanced 
suggests that the degree of influence appropriate for marketers is an 
especially important consideration. 
 
Marketing in general is held in poor public regard, particularly because 
there is little assurance that a marketer is being open and honest 
(Barksdale et al., 1976; Murphy & Bloom, 1992; Murphy, 2010). 
Regrettably, social marketers are not exempt from misusing the tools of 
marketing. Anti-vaccinators have been fairly challenged for making 
dubious claims, such as promoting the link between autism and the MMR 
(measles, mumps and rubella) vaccine. Anti-smoking advocates have 
sometimes manipulated or even fabricated data, especially about the ill 
effects of second-hand smoke (Donovan & Henley, 2010; Hatton, 1994; 
Johnstone & Ulyatt, 1991). Other social marketers have demeaned and 
even damaged some members in society in promoting their causes 
(Donovan et al., 2008; Donovan et al., 2009). All such ethical violations 
remind us that a stated objective of the social good, even in the absence of 
a profit motive, does not immunize against unethical behaviour. 
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Is coercion ethically permissible? Social marketing definitions are 
surprisingly variable about this matter. Many definitions explicitly limit 
social marketing influence to ‘voluntary behaviour’ (e.g. Andreasen, 1995; 
Dann, 2010; Grier & Bryant, 2005; Smith, 2000). Rothschild (1999, 2001) 
similarly excludes coercion from social marketing influence efforts, which 
he places between education and information on the one hand and law on 
the other. However, others argue that the exclusion of more coercive 
influence is somewhat artificial and that legislation and regulation are 
important social marketing tools (Donovan, 2011). Moreover, Donovan 
and Henley (2010) note that commercial marketers are often willing to 
push their influence and will wield monopoly power if available. 
 
Of course, no ends automatically justify the means, but if the ends are 
in doubt, then an extra degree of caution around the means seems 
appropriate. ‘Forcing people to get vaccinated is not like forcing people to 
drive on the right side of the road, because the risks and benefits of 
vaccination are contestable, the phenomenology of vaccination is complex, 
and features such as parental rights are influential’ (Holland, 2007: 159). 
 
Marketing in general aims to influence people. Influence invokes 
concerns about autonomy and self-determination. As influence moves 
from education towards regulation (Rothschild, 1999), these concerns 
seem to grow. If regulation is going to be used, then it would appear that 
there needs to be a great deal of confidence around the social good that is 
being offered, including whether it is justified even if in opposition to 
individual choices. 
Conclusion 
We challenge the view that social marketing is in its nature more 
ethical than commercial marketing and suggest that social marketers are 
not entitled to claim any inherent ethical praiseworthiness relative to 
commercial marketers. We suggest that the following might be added to 
the list of ‘mythunderstandings’ offered by Donovan (2011): social 
marketing is not inherently ethically good. 
 
More specifically, we propose that differentiating commercial and 
social marketers in terms of their intentions is problematic as intentions 
reflect internal states that are not readily available to an external observer, 
and agents pursue multiple goals and possess a variety of intentions. Being 




one’s activities; being socially oriented does not mean that self-serving 
motivations are not salient and sometimes even primary. 
 
Even if we accept that the social good is the primary objective of social 
marketers, the problem becomes one of what constitutes the social good. 
Social marketing purports to provide benefits to the individuals it serves, 
but consulting with those individuals is not assured and, even if conducted, 
may proceed even in denial of the stated interests of at least some of the 
individuals. Social marketing serves the community or society at large; 
individual preferences and wishes are subordinated to this objective. This 
is a striking contrast with ‘less ethical’ commercial marketing, in which 
individual interests are king and caveat emptor gives the individual the 
ultimate power of veto. 
 
A consideration of individual rights evokes the problem of how much 
influence is appropriate. Social marketers often shy away from any 
involuntary behavioural change, which perhaps reflects an understanding 
that promotion of the social good may be at odds with supporting 
autonomy and self-determination, which are generally considered to be 
important rights. 
 
Our chapter explores some of the unique ethical issues confronting 
social marketing in the context of vaccination, but these issues also apply 
to social marketing more broadly (e.g. Holden & Cox, 2013). We believe 
that many if not most social marketers are motivated to be good citizens 
and to help society. Nonetheless, we argue that they are obliged to 
examine the ethicality of their goals and to assess whether what they are 
doing is morally legitimate.  
 
In particular, we suggest that there are three questions that social 
marketers might ask to inform themselves of the ethicality of their 
practice: Is the social good good? How are individual rights 
accommodated? What degree of influence is ethically justifiable? There 
are unfortunately no ready answers to these questions; they must be 
explored on a case-by-case basis, and even then the questions may be 
difficult to answer.  
 
Social marketing has the power and the potential to benefit some 
individuals, but it also has the potential to limit or even harm others. We 
acknowledge that this chapter poses some tough questions for social 
marketing. The chapter is offered as a preventative measure, as a ‘shot in 
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the arm’ encouraging consideration of the questions raised – even if they 
are difficult to answer. Our hope is to protect social marketers from hubris 
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